ABOUT ELT
Emanuela Lazzaroni-Tealdi is an experienced Senior Embryologist and IVF consultant with a demonstrated and successful long history of working in the medical reproductive industry and the leading centers in New York and New Jersey areas.
Emanuela Lazzaroni-Tealdi studied Biology at the University of Pisa, in Italy, passing all classes with the highest grade with distinction, later she earned her Bachelor degree in Biological Sciences from the Hunter College of the City University of New York being part of the Dean list.
Emanuela in 2013 received her Master Degree in Biomedical Sciences with Specialization in Clinical Embryology & Andrology from EVMS with a GPA score of 4.00.
Emanuela Lazzaroni-Tealdi started working in the Embryology field in early 2008, then after working several years as Senior Embryologist in New York City area she became a well known Senior Embryologist and Lab Manager in NYC and NJ area.
Ema worked for several pioneers of IVF as Dr. Andrea Vidali, worldwide specialist in endometriosis, and Dr. Norbert Gleicher, first in the world for transvaginal oocyte retrieval and much more, for the most leading center in New York (NYU Langone, Northwell, CHR, New Hope Fertility Center etc), under her supervision the laboratories have always maintained the highest standards of Key Performance Indicators.
She contributed to many scientific publications, and in 2015 Ema published, as first author, in Plos One a paper regarding oocyte scoring based on morphology, that came out to be the first report, in the literature, that shows that oocytes scoring system is predictive and additive to embryo scoring.
In her carrier, Emanuela Lazzaroni-Tealdi trained in Embryology and in all aspects of IVF several Ph.D scientists, who later became Lab Directors of prestigious IVF Laboratories worldwide.
Patient Reproductive Health Guide/Strategist/Coach:
Not only does Emanuela excel in her technical skills, but she also demonstrates a remarkable attitude when interacting with patients undergoing the challenging process of in vitro fertilization. Her compassionate nature allows her to effectively communicate with patients, providing them with the necessary support and guidance throughout their IVF journey.
Emanuela's dedication to patient care extends beyond mere assistance. She takes the time to educate patients about the various IVF techniques, ensuring they have a comprehensive understanding of the procedures involved. Her ability to explain complex concepts in a clear and concise manner helps alleviate any concerns or anxieties patients may have.
Furthermore, Emanuela's empathetic approach allows her to provide comfort to patients during what can be an emotionally taxing experience. She offers a listening ear and a shoulder to lean on, understanding the unique challenges that individuals face during their fertility treatments. Her ability to provide solace and reassurance to patients is truly commendable.
In addition to her supportive role, Emanuela also provides valuable advice and suggestions to patients. Drawing from her vast experience in the field, she offers practical recommendations to optimize the chances of success during IVF treatments. Her guidance helps patients make informed decisions and empowers them to actively participate in their own fertility journey.
Emanuela Lazzaroni-Tealdi's professional demeanor, exceptional skills in IVF and Lab management, and her compassionate approach to patient care make her an outstanding professional in the field. Her commitment to excellence and unwavering dedication to helping patients achieve their dreams of parenthood set her apart as a true leader in the field of in vitro fertilization.
EXPERIENCE
IVF Laboratory Manager/Senior Embryologist, New Hope Fertility Center, New York, NY from 2020 to 2022;
IVF Laboratory Supervisor and Senior Embryologist, Global Fertility & Genetics , New York, NY From 2019 to 2020;
IVF Laboratory Supervisor/Senior Embryologist CHR Center for Human Reproduction, New York, NY From 2015 to 2019;
Senior Embryologist, CHR Center for Human Reproduction, New York, NY from 2013 to 2015;
Embryologist, CHR Center for Human Reproduction, New York, NY from 2011 to 2013;
Embryologist, American Fertility Services, New York, NY from 2010 to 2011;
Embryologist Training, American Fertility Services, New York, NY 2008 to August 2009;
SKILLS
Laboratory QA, QC, QI;
Handling herself CAP, NYSDOH, and FDA inspections.
Supervision of the work of the Laboratory staff;
Review of Laboratory procedures, records, methodologies and results.
Evaluation of integrity of the samples;
Excellent in organizing team work, in making plans assigning priorities work to laboratory staff;
Excellent in handling difficulties and solving problems;
Very proficient in advising, orienting and training staff;
Excellent communication skills;
Very organized Laboratory Supervisor;
Evaluates when staff in competent or not;
Maintaining an understanding of human biology, reproductive biology, embryology, infertility and assisted reproductive technology;
Having knowledge of and complying with quality control, ethical issues, and regulations surrounding gametes, tissues and embryo handling;
Care and maintenance of equipment;
Consult and determination of fertility levels of individuals;
Collection of eggs and sperm (gametes) from patients for processing (oocytes retrievals, etc...);
Maintaining viability of gametes, tissues and embryos during process in micromanipulation and testing of suitability of each gamete;
Preparation of gametes and the environment for in vitro fertilization (oocytes stripping etc...);
Conventional IVF and facilitation of fertilization using assisted reproductive technologies (ART) to help like ICSI;
Preservation of gametes and embryos for future use;
Embryo culture;
Embryos manipulation like embryo biopsy, chemical assistant hatching, laser hatching;
Embryo and oocyte cryopreservation with slow freezing and vitrification
Monitoring of embryo development;
Embryo selection for transfer to recipient women, research or other intended use and the implantation of embryos into reproductive organs;
Monitoring and maintaining cryobanks;
Blood chemistry analysis;
Andrology, sperm isolation by density gradient, semen analysis, semen cryopreservation;
Very proficient in all Clinical Laboratory Procedures in particular involving Human in Vitro Fertilization
Excellent communication skills especially regarding human biology and IVF steps and dynamics.
PUBBLICATIONS
Oocyte Scoring Enhances Embryo-Scoring in Predicting Pregnancy Chances with IVF Where It Counts Most. (First Author) Lazzaroni-Tealdi E, Barad DH, Albertini DF, Yu Y, Kushnir VA, Russell H, Wu YG, Gleicher N. PLoS One. 2015 Dec 2;10(12):e0143632. doi: 10.1371/journal.pone.0143632. eCollection 2015.
Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval. Wu YG, Barad DH, Kushnir VA, Lazzaroni E, Wang Q, Albertini DF, Gleicher N. J Endocrinol. 2015 Sep;226(3):167-80. doi: 10.1530/JOE-15-0246. Epub 2015 Aug 11.
Effect of inter-cycle interval on oocyte production in humans in the presence of the weak androgen DHEA and follicle stimulating hormone: a case-control study. Barad DH, Kushnir VA, Lee HJ, Lazzaroni E, Gleicher N. Reprod Biol Endocrinol. 2014 Jul 21;12:68. doi: 10.1186/1477-7827-12-68.
A randomized clinical trial of endometrial perfusion with granulocyte colonystimulating factor in in vitro fertilization cycles: impact on endometrial thickness and clinical pregnancy rates. Barad DH, Yu Y, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, Gleicher N. Fertil Steril. 2014 Mar;101(3):710-5. doi: 10.1016/j.fertnstert.2013.12.016. Epub 2014 Jan 11.
FMR1-dependent variability of ovarian aging patterns is already apparent in young oocyte donors. Gleicher N, Kim A, Barad DH, Shohat-Tal A, Lazzaroni E, Michaeli T, Lee HJ, Kushnir VA, Weghofer A. Reprod Biol Endocrinol. 2013 Aug 16;11:80. doi: 10.1186/1477-7827-11-80.
Is androgen production in association with immune system activation potential evidence for existence of a functional adrenal/ovarian autoimmune system in women? Gleicher N, Weghofer A, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH. Reprod Biol Endocrinol. 2013 Jun 27;11:58. doi: 10.1186/1477-7827-11-58.
Clinical relevance of combined FSH and AMH observations in infertile women. Gleicher N, Kim A, Kushnir V, Weghofer A, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH. J Clin Endocrinol Metab. 2013 May;98(5):2136-45. doi: 10.1210/jc.2013-1051. Epub 2013 Mar 26.
Hypoandrogenism in association with diminished functional ovarian reserve. Gleicher N, Kim A, Weghofer A, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH. Hum Reprod. 2013 Apr;28(4):1084-91. doi: 10.1093/humrep/det033. Epub 2013 Feb 20.
Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR). Gleicher N, Kim A, Weghofer A, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH. J Assist Reprod Genet. 2013 Jan;30(1):49-62. doi: 10.1007/s10815-012-9890-z. Epub 2012 Dec 5.
EXPERIENCE
IVF Laboratory Manager/Senior Embryologist, New Hope Fertility Center, New York, NY from 2020 to 2022;
IVF Laboratory Supervisor and Senior Embryologist, Global Fertility & Genetics , New York, NY From 2019 to 2020;
IVF Laboratory Supervisor/Senior Embryologist CHR Center for Human Reproduction, New York, NY From 2015 to 2019;
Senior Embryologist, CHR Center for Human Reproduction, New York, NY from 2013 to 2015;
Embryologist, CHR Center for Human Reproduction, New York, NY from 2011 to 2013;
Embryologist, American Fertility Services, New York, NY from 2010 to 2011;
Embryologist Training, American Fertility Services, New York, NY 2008 to August 2009;
SKILLS
Laboratory QA, QC, QI;
Handling herself CAP, NYSDOH, and FDA inspections.
Supervision of the work of the Laboratory staff;
Review of Laboratory procedures, records, methodologies and results.
Evaluation of integrity of the samples;
Excellent in organizing team work, in making plans assigning priorities work to laboratory staff;
Excellent in handling difficulties and solving problems;
Very proficient in advising, orienting and training staff;
Excellent communication skills;
Very organized Laboratory Supervisor;
Evaluates when staff in competent or not;
Maintaining an understanding of human biology, reproductive biology, embryology, infertility and assisted reproductive technology;
Having knowledge of and complying with quality control, ethical issues, and regulations surrounding gametes, tissues and embryo handling;
Care and maintenance of equipment;
Consult and determination of fertility levels of individuals;
Collection of eggs and sperm (gametes) from patients for processing (oocytes retrievals, etc...);
Maintaining viability of gametes, tissues and embryos during process in micromanipulation and testing of suitability of each gamete;
Preparation of gametes and the environment for in vitro fertilization (oocytes stripping etc...);
Conventional IVF and facilitation of fertilization using assisted reproductive technologies (ART) to help like ICSI;
Preservation of gametes and embryos for future use;
Embryo culture;
Embryos manipulation like embryo biopsy, chemical assistant hatching, laser hatching;
Embryo and oocyte cryopreservation with slow freezing and vitrification
Monitoring of embryo development;
Embryo selection for transfer to recipient women, research or other intended use and the implantation of embryos into reproductive organs;
Monitoring and maintaining cryobanks;
Blood chemistry analysis;
Andrology, sperm isolation by density gradient, semen analysis, semen cryopreservation;
Very proficient in all Clinical Laboratory Procedures in particular involving Human in Vitro Fertilization
Excellent communication skills especially regarding human biology and IVF steps and dynamics.
PUBBLICATIONS
Oocyte Scoring Enhances Embryo-Scoring in Predicting Pregnancy Chances with IVF Where It Counts Most. (First Author) Lazzaroni-Tealdi E, Barad DH, Albertini DF, Yu Y, Kushnir VA, Russell H, Wu YG, Gleicher N. PLoS One. 2015 Dec 2;10(12):e0143632. doi: 10.1371/journal.pone.0143632. eCollection 2015.
Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval. Wu YG, Barad DH, Kushnir VA, Lazzaroni E, Wang Q, Albertini DF, Gleicher N. J Endocrinol. 2015 Sep;226(3):167-80. doi: 10.1530/JOE-15-0246. Epub 2015 Aug 11.
Effect of inter-cycle interval on oocyte production in humans in the presence of the weak androgen DHEA and follicle stimulating hormone: a case-control study. Barad DH, Kushnir VA, Lee HJ, Lazzaroni E, Gleicher N. Reprod Biol Endocrinol. 2014 Jul 21;12:68. doi: 10.1186/1477-7827-12-68.
A randomized clinical trial of endometrial perfusion with granulocyte colonystimulating factor in in vitro fertilization cycles: impact on endometrial thickness and clinical pregnancy rates. Barad DH, Yu Y, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, Gleicher N. Fertil Steril. 2014 Mar;101(3):710-5. doi: 10.1016/j.fertnstert.2013.12.016. Epub 2014 Jan 11.
FMR1-dependent variability of ovarian aging patterns is already apparent in young oocyte donors. Gleicher N, Kim A, Barad DH, Shohat-Tal A, Lazzaroni E, Michaeli T, Lee HJ, Kushnir VA, Weghofer A. Reprod Biol Endocrinol. 2013 Aug 16;11:80. doi: 10.1186/1477-7827-11-80.
Is androgen production in association with immune system activation potential evidence for existence of a functional adrenal/ovarian autoimmune system in women? Gleicher N, Weghofer A, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH. Reprod Biol Endocrinol. 2013 Jun 27;11:58. doi: 10.1186/1477-7827-11-58.
Clinical relevance of combined FSH and AMH observations in infertile women. Gleicher N, Kim A, Kushnir V, Weghofer A, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH. J Clin Endocrinol Metab. 2013 May;98(5):2136-45. doi: 10.1210/jc.2013-1051. Epub 2013 Mar 26.
Hypoandrogenism in association with diminished functional ovarian reserve. Gleicher N, Kim A, Weghofer A, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH. Hum Reprod. 2013 Apr;28(4):1084-91. doi: 10.1093/humrep/det033. Epub 2013 Feb 20.
Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR). Gleicher N, Kim A, Weghofer A, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH. J Assist Reprod Genet. 2013 Jan;30(1):49-62. doi: 10.1007/s10815-012-9890-z. Epub 2012 Dec 5.